{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T17:58:48Z","timestamp":1795111128510,"version":"4.10.3"},"reference-count":199,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T00:00:00Z","timestamp":1709164800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.jaci.2024.02.011","type":"journal-article","created":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T11:21:59Z","timestamp":1708514519000},"page":"1181-1193","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":143,"title":["Airway hyperresponsiveness in asthma: The role of the epithelium"],"prefix":"10.1016","volume":"153","author":[{"given":"Peter","family":"Bradding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celeste","family":"Porsbjerg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9anne","family":"C\u00f4t\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven-Erik","family":"Dahl\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teal S.","family":"Hallstrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher E.","family":"Brightling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2024.02.011_bib2","doi-asserted-by":"crossref","first-page":"460","DOI":"10.3389\/fphys.2012.00460","article-title":"Airway hyperresponsiveness in asthma: mechanisms, clinical significance, and treatment","volume":"3","author":"Brannan","year":"2012","journal-title":"Front Physiol"},{"key":"10.1016\/j.jaci.2024.02.011_bib3","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/cea.12506","article-title":"Mechanisms of airway hyper-responsiveness in asthma: the past, present and yet to come","volume":"45","author":"Chapman","year":"2015","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2024.02.011_bib4","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/S0140-6736(08)61447-6","article-title":"Wheezing and bronchial hyper-responsiveness in early childhood as predictors of newly diagnosed asthma in early adulthood: a longitudinal birth-cohort study","volume":"372","author":"Stern","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2024.02.011_bib5","article-title":"Airway smooth muscle hypercontractility in asthma","volume":"2013","author":"Berair","year":"2013","journal-title":"J Allergy (Cairo)"},{"key":"10.1016\/j.jaci.2024.02.011_bib6","doi-asserted-by":"crossref","first-page":"8907","DOI":"10.3390\/ijms21238907","article-title":"The airway epithelium\u2014a central player in asthma pathogenesis","volume":"21","author":"Calven","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jaci.2024.02.011_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.ai.2019.05.001","article-title":"The airway epithelium in asthma","volume":"142","author":"Bonser","year":"2019","journal-title":"Adv Immunol"},{"key":"10.1016\/j.jaci.2024.02.011_bib8","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/j.jaci.2020.04.010","article-title":"Epithelial barriers in allergy and asthma","volume":"145","author":"Hellings","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.02.011_bib9","doi-asserted-by":"crossref","first-page":"487","DOI":"10.2147\/JAA.S324080","article-title":"The role of defective epithelial barriers in allergic lung disease and asthma development","volume":"15","author":"Noureddine","year":"2022","journal-title":"J Asthma Allergy"},{"key":"10.1016\/j.jaci.2024.02.011_bib10","doi-asserted-by":"crossref","unstructured":"Hogg JC. Chapter 6 - Airway Pathology, In: Barnes PJ, Drazen JM, Rennard SI, Thomson NC, editors, Asthma and COPD (Second Edition), Oxford: Academic Press, 2009, 71\u201381.","DOI":"10.1016\/B978-0-12-374001-4.00006-7"},{"key":"10.1016\/j.jaci.2024.02.011_bib11","doi-asserted-by":"crossref","first-page":"200186","DOI":"10.1183\/16000617.0186-2020","article-title":"Structure and function of small airways in asthma patients revisited","volume":"30","author":"Van den Bosch","year":"2021","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.jaci.2024.02.011_bib12","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/rr176","article-title":"The role of surfactant in asthma","volume":"3","author":"Hohlfeld","year":"2002","journal-title":"Respir Res"},{"key":"10.1016\/j.jaci.2024.02.011_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2022.898208","article-title":"Fixed airflow obstruction in asthma: a problem of the whole lung not of just the airways","volume":"13","author":"Rutting","year":"2022","journal-title":"Front Physiol"},{"key":"10.1016\/j.jaci.2024.02.011_bib14","doi-asserted-by":"crossref","first-page":"1801028","DOI":"10.1183\/13993003.01028-2018","article-title":"Lung elastic recoil and ventilation heterogeneity of diffusion-dependent airways in older people with asthma and fixed airflow obstruction","volume":"53","author":"Tonga","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2024.02.011_bib15","article-title":"The pivotal role of airway smooth muscle in asthma pathophysiology","volume":"2011","author":"Ozier","year":"2011","journal-title":"J Allergy (Cairo)"},{"key":"10.1016\/j.jaci.2024.02.011_bib16","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1183\/13993003.01359-2015","article-title":"Treatable traits: toward precision medicine of chronic airway diseases","volume":"47","author":"Agusti","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2024.02.011_bib17","first-page":"1","volume":"5","author":"Lauzon","year":"2016","journal-title":"Airway hyperresponsiveness; smooth muscle as the principal actor. F1000Res"},{"key":"10.1016\/j.jaci.2024.02.011_bib18","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.3390\/jpm11111229","article-title":"Airway wall remodeling in childhood asthma\u2014a personalized\u00a0perspective from cell type\u2013specific biology","volume":"11","author":"Fang","year":"2021","journal-title":"J Pers Med"},{"key":"10.1016\/j.jaci.2024.02.011_bib19","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.jaci.2012.01.059","article-title":"Pediatric severe asthma is characterized by eosinophilia and remodeling without TH2 cytokines","volume":"129","author":"Bossley","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.02.011_bib20","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1164\/rccm.200707-977OC","article-title":"Increased airway smooth muscle mass in children with asthma, cystic fibrosis, and non\u2013cystic fibrosis bronchiectasis","volume":"177","author":"Regamey","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2024.02.011_bib21","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.jaci.2012.08.044","article-title":"Increased airway smooth muscle in preschool wheezers who have asthma at school age","volume":"131","author":"O\u2019Reilly","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.02.011_bib22","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1165\/rcmb.2019-0149ED","article-title":"Epigenetic links to airway smooth muscle proliferation","volume":"61","author":"Jia","year":"2019","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.jaci.2024.02.011_bib23","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1152\/japplphysiol.00950.2012","article-title":"Airway smooth muscle in the pathophysiology and treatment of asthma","volume":"114","author":"Doeing","year":"2013","journal-title":"J Appl Physiol (1985)"},{"key":"10.1016\/j.jaci.2024.02.011_bib24","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.jaip.2016.11.030","article-title":"Airway hyperresponsiveness in asthma: measurement and clinical relevance","volume":"5","author":"Nair","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2024.02.011_bib25","doi-asserted-by":"crossref","first-page":"301ra129","DOI":"10.1126\/scitranslmed.aab3142","article-title":"TH2 and TH17 inflammatory pathways are reciprocally regulated in asthma","volume":"7","author":"Choy","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jaci.2024.02.011_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0121781","article-title":"Airway response to methacholine following eucapnic voluntary hyperpnea in athletes","volume":"10","author":"Bougault","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jaci.2024.02.011_bib27","doi-asserted-by":"crossref","first-page":"1801033","DOI":"10.1183\/13993003.01033-2018","article-title":"ERS technical standard on bronchial challenge testing: pathophysiology and\u00a0methodology of indirect airway challenge testing","volume":"52","author":"Hallstrand","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2024.02.011_bib28","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.iac.2018.06.010","article-title":"Bronchoprovocation testing in asthma: an update","volume":"38","author":"Comberiati","year":"2018","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaci.2024.02.011_bib29","doi-asserted-by":"crossref","first-page":"411S","DOI":"10.1378\/chest.123.3_suppl.411S","article-title":"Airway hyperresponsiveness","volume":"123","author":"O\u2019Byrne","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.jaci.2024.02.011_bib30","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1016\/j.jaci.2021.03.035","article-title":"Airway smooth muscle pathophysiology in asthma","volume":"147","author":"Camoretti-Mercado","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.02.011_bib31","doi-asserted-by":"crossref","first-page":"1601526","DOI":"10.1183\/13993003.01526-2016","article-title":"ERS technical standard on bronchial challenge testing: general considerations and performance of methacholine challenge tests","volume":"49","author":"Coates","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2024.02.011_bib32","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.jaci.2010.08.028","article-title":"Airway hyperresponsiveness to mannitol and methacholine and exhaled nitric oxide: a random-sample population study","volume":"126","author":"Sverrild","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.02.011_bib33","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1152\/japplphysiol.01618.2011","article-title":"Airway closure on imaging relates to airway hyperresponsiveness and peripheral airway disease in asthma","volume":"113","author":"Farrow","year":"2012","journal-title":"J Appl Physiol (1985)"},{"key":"10.1016\/j.jaci.2024.02.011_bib34","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1164\/rccm.200412-1667OC","article-title":"Inflammatory basis of exercise-induced bronchoconstriction","volume":"172","author":"Hallstrand","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2024.02.011_bib35","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3390\/jor1030018","article-title":"The effect of high flow nasal cannula therapy in exercised-induced asthma of children","volume":"1","author":"ter Wee","year":"2021","journal-title":"J Respir"},{"key":"10.1016\/j.jaci.2024.02.011_bib36","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1365-2222.2007.02878.x","article-title":"Relationship between airway responsiveness to mannitol and to methacholine and markers of airway inflammation, peak flow variability and quality of life in asthma patients","volume":"38","author":"Porsbjerg","year":"2008","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2024.02.011_bib37","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.jaip.2015.02.005","article-title":"Combining the mannitol test and FeNO in the assessment of poorly controlled asthma","volume":"3","author":"Porsbjerg","year":"2015","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2024.02.011_bib38","doi-asserted-by":"crossref","first-page":"2101865","DOI":"10.1183\/13993003.01865-2021","article-title":"Location of eosinophils in the airway wall is critical for specific features of airway hyperresponsiveness and T2 inflammation in asthma","volume":"60","author":"Al-Shaikhly","year":"2022","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2024.02.011_bib39","doi-asserted-by":"crossref","first-page":"4S","DOI":"10.1378\/chest.10-0100","article-title":"The relationship of airway hyperresponsiveness and airway inflammation: airway hyperresponsiveness in asthma: its measurement and clinical significance","volume":"138","author":"Busse","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.jaci.2024.02.011_bib40","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1146\/annurev-pathol-012414-040343","article-title":"Pathobiology of severe asthma","volume":"10","author":"Trejo Bittar","year":"2015","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.jaci.2024.02.011_bib41","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1164\/rccm.201110-1849OC","article-title":"Airway smooth muscle hypertrophy and hyperplasia in asthma","volume":"185","author":"James","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2024.02.011_bib42","doi-asserted-by":"crossref","first-page":"S246","DOI":"10.1164\/ajrccm\/154.6_Pt_2.S246","article-title":"Longitudinal analyses of airway responsiveness and pulmonary function decline","volume":"154","author":"Rijcken","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2024.02.011_bib43","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1056\/NEJMoa022363","article-title":"A longitudinal, population-based, cohort study of childhood asthma followed to adulthood","volume":"349","author":"Sears","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2024.02.011_bib44","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1164\/ajrccm.160.1.9809104","article-title":"Lung function and sputum characteristics of patients with severe asthma during an induced exacerbation by double-blind steroid withdrawal","volume":"160","author":"in\u2019t Veen","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2024.02.011_bib45","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1164\/ajrccm.163.2.9912091","article-title":"Predictive markers of asthma exacerbation during stepwise dose reduction of inhaled corticosteroids","volume":"163","author":"Leuppi","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2024.02.011_bib46","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1016\/j.jaip.2020.03.011","article-title":"Management of exercise-induced bronchoconstriction in athletes","volume":"8","author":"Koya","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2024.02.011_bib47","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1183\/09031936.03.00008403","article-title":"Indirect airway challenges","volume":"21","author":"Joos","year":"2003","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2024.02.011_bib48","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1164\/ajrccm.159.6.9805093","article-title":"Exercise-induced bronchospasm in children: effects of asthma severity","volume":"159","author":"Cabral","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2024.02.011_bib49","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jaci.2023.03.001","article-title":"Airway hyperresponsiveness reflects corticosteroid-sensitive mast cell involvement across asthma phenotypes","volume":"152","author":"Hvidtfeldt","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.02.011_bib50","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1164\/ajrccm.159.4.9806052","article-title":"Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group","volume":"159","author":"Sont","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2024.02.011_bib51","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1164\/ajrccm.162.4.9912103","article-title":"Screening for bronchial hyperresponsiveness using methacholine and adenosine monophosphate. Relationship to asthma severity and beta2-receptor genotype","volume":"162","author":"Fowler","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2024.02.011_bib52","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1183\/09031936.00180313","article-title":"Specific inhalation challenge in the diagnosis of occupational asthma: consensus statement","volume":"43","author":"Vandenplas","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2024.02.011_bib53","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.jaci.2016.05.029","article-title":"Exercise-induced bronchoconstriction update\u20142016","volume":"138","author":"Weiler","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.02.011_bib54","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1111\/all.14658","article-title":"Direct and indirect bronchoprovocation tests in dose\u2013response studies of inhaled corticosteroids: past, present, and future directions","volume":"76","author":"Blais","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2024.02.011_bib55","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S1081-1206(10)60353-5","article-title":"Direct and indirect challenges in the clinical assessment of asthma","volume":"103","author":"Cockcroft","year":"2009","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2024.02.011_bib56","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1111\/all.14748","article-title":"Mast cell\u2013derived serotonin enhances methacholine-induced airway hyperresponsiveness in house dust mite\u2013induced experimental asthma","volume":"76","author":"Mendez-Enriquez","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2024.02.011_bib57","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.161898","article-title":"Insulin increases sensory nerve density and reflex bronchoconstriction in obese mice","volume":"7","author":"Calco","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.jaci.2024.02.011_bib58","doi-asserted-by":"crossref","first-page":"18S","DOI":"10.1378\/chest.10-0088","article-title":"Direct challenge tests: airway hyperresponsiveness in asthma: its measurement and clinical significance","volume":"138","author":"Cockcroft","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.jaci.2024.02.011_bib59","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41533-020-00202-y","article-title":"The use of a direct bronchial challenge test in primary care to diagnose asthma","volume":"30","author":"Bins","year":"2020","journal-title":"NPJ Prim Care Respir Med"},{"key":"10.1016\/j.jaci.2024.02.011_bib60","doi-asserted-by":"crossref","DOI":"10.3389\/falgy.2022.864890","article-title":"Daily inhaled corticosteroids treatment abolishes airway hyperresponsiveness to mannitol in defence and police recruits","volume":"3","author":"Lake","year":"2022","journal-title":"Front Allergy"},{"key":"10.1016\/j.jaci.2024.02.011_bib61","doi-asserted-by":"crossref","first-page":"344","DOI":"10.4046\/trd.2017.0051","article-title":"Nonspecific bronchoprovocation test","volume":"80","author":"Lee","year":"2017","journal-title":"Tuberc Respir Dis (Seoul)"},{"key":"10.1016\/j.jaci.2024.02.011_bib62","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.rmed.2018.10.020","article-title":"Differentiation of adult severe asthma from difficult-to-treat asthma\u2014outcomes of a systematic assessment protocol","volume":"145","author":"von B\u00fclow","year":"2018","journal-title":"Respir Med"},{"key":"10.1016\/j.jaci.2024.02.011_bib63","doi-asserted-by":"crossref","first-page":"4979","DOI":"10.1172\/JCI126402","article-title":"Airway epithelium-shifted mast cell infiltration regulates asthmatic inflammation via IL-33 signaling","volume":"129","author":"Altman","year":"2019","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2024.02.011_bib64","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.jaci.2006.07.012","article-title":"Mechanisms of airway hyperresponsiveness","volume":"118","author":"Cockcroft","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.02.011_bib65","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1164\/rccm.202209-1707OC","article-title":"Distinct epithelial\u2013innate immune cell transcriptional circuits underlie airway hyperresponsiveness in asthma","volume":"207","author":"Murphy","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2024.02.011_bib66","first-page":"2","article-title":"The interplay between airway epithelium and the immune system\u2014a primer for the respiratory clinician","volume":"38","author":"Weinstock","year":"2021","journal-title":"Paediatr Respir Rev"},{"key":"10.1016\/j.jaci.2024.02.011_bib67","doi-asserted-by":"crossref","first-page":"787128","DOI":"10.3389\/falgy.2021.787128","article-title":"Airway basal cells, protectors of epithelial walls in health and respiratory diseases","volume":"2","author":"Ruysseveldt","year":"2021","journal-title":"Front Allergy"},{"key":"10.1016\/j.jaci.2024.02.011_bib68","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1111\/all.14421","article-title":"Epithelial cell dysfunction, a major driver of asthma development","volume":"75","author":"Heijink","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2024.02.011_bib69","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.975914","article-title":"Epithelial cell alarmin cytokines: frontline mediators of the asthma inflammatory response","volume":"13","author":"Duchesne","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2024.02.011_bib70","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1165\/rcmb.2012-0304OC","article-title":"Transcription of interleukin-25 and extracellular release of the protein is regulated by allergen proteases in airway epithelial cells","volume":"49","author":"Kouzaki","year":"2013","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.jaci.2024.02.011_bib71","doi-asserted-by":"crossref","first-page":"4375","DOI":"10.4049\/jimmunol.1003020","article-title":"The danger signal, extracellular ATP, is a sensor for an airborne allergen and triggers IL-33 release and innate Th2-type responses","volume":"186","author":"Kouzaki","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2024.02.011_bib72","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/j.jaci.2015.10.003","article-title":"Airway epithelial dual oxidase 1 mediates allergen-induced IL-33 secretion and activation of type 2 immune responses","volume":"137","author":"Hristova","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.02.011_bib73","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1165\/ajrcmb.10.5.8179909","article-title":"Interleukin-4, -5, and -6 and tumor necrosis factor-alpha in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines","volume":"10","author":"Bradding","year":"1994","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.jaci.2024.02.011_bib74","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/cea.12675","article-title":"Mast cells in asthma\u2014state of the art","volume":"46","author":"Bradding","year":"2016","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2024.02.011_bib75","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.jaci.2019.10.037","article-title":"IL-13 and IL-4, but not IL-5 nor IL-17A, induce hyperresponsiveness in isolated human small airways","volume":"145","author":"Manson","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.02.011_bib76","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41392-019-0079-0","article-title":"Targeting cell signaling in allergic asthma","volume":"4","author":"Athari","year":"2019","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.jaci.2024.02.011_bib77","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jaci.2006.09.045","article-title":"Class switch recombination to IgE in the bronchial mucosa of atopic and nonatopic patients with asthma","volume":"119","author":"Takhar","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.02.011_bib78","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1084\/jem.20070956","article-title":"Bronchial smooth muscle remodeling involves calcium-dependent enhanced mitochondrial biogenesis in asthma","volume":"204","author":"Trian","year":"2007","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2024.02.011_bib79","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S0140-6736(95)90409-3","article-title":"Bronchoprotective role for endogenous prostaglandin E2","volume":"345","author":"Pavord","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2024.02.011_bib80","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/cei.13191","article-title":"Increased beta2-adrenoceptor phosphorylation in airway smooth muscle in severe asthma: possible role of mast cell\u2013derived growth factors","volume":"194","author":"Chachi","year":"2018","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaci.2024.02.011_bib81","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/j.jaci.2017.04.005","article-title":"Phenotypic and genetic aspects of epithelial barrier function in asthmatic patients","volume":"139","author":"Loxham","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.02.011_bib82","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/nm.2678","article-title":"Asthma phenotypes: the evolution from clinical to molecular approaches","volume":"18","author":"Wenzel","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2024.02.011_bib83","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1164\/rccm.200903-0392OC","article-title":"T-helper type 2\u2013driven inflammation defines major subphenotypes of asthma","volume":"180","author":"Woodruff","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2024.02.011_bib84","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1111\/all.15376","article-title":"Airway remodelling rather than cellular infiltration characterizes both type 2 cytokine biomarker-high and -low severe asthma","volume":"77","author":"Khalfaoui","year":"2022","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2024.02.011_bib85","doi-asserted-by":"crossref","first-page":"00483","DOI":"10.1183\/23120541.00483-2022","article-title":"Distribution of type 2 biomarkers and association with severity, clinical characteristics and comorbidities in the BREATHE real-life asthma population","volume":"9","author":"Frossing","year":"2023","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.jaci.2024.02.011_bib86","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/cea.13966","article-title":"Airway gene expression identifies subtypes of type 2 inflammation in severe asthma","volume":"52","author":"Frossing","year":"2022","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2024.02.011_bib87","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1164\/rccm.200711-1754OC","article-title":"Cluster analysis and clinical asthma phenotypes","volume":"178","author":"Haldar","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2024.02.011_bib88","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1080\/02770903.2020.1780255","article-title":"Airway hyperresponsiveness to mannitol improves in both type 2 high and type 2 low asthma after specialist management","volume":"58","author":"Hvidtfeldt","year":"2021","journal-title":"J Asthma"},{"key":"10.1016\/j.jaci.2024.02.011_bib89","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jaci.2022.10.028","article-title":"Eosinophil depletion with benralizumab is associated with attenuated mannitol airway hyperresponsiveness in severe uncontrolled eosinophilic asthma","volume":"151","author":"Chan","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.02.011_bib90","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1056\/NEJMoa012705","article-title":"Mast-cell infiltration of airway smooth muscle in asthma","volume":"346","author":"Brightling","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2024.02.011_bib91","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1164\/ajrccm\/136.2.379","article-title":"Bronchoalveolar cell profiles of asthmatic and nonasthmatic subjects","volume":"136","author":"Kirby","year":"1987","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.jaci.2024.02.011_bib92","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1111\/resp.12142","article-title":"Relationship between airway pathophysiology and airway inflammation in older asthmatics","volume":"18","author":"Porsbjerg","year":"2013","journal-title":"Respirology"},{"key":"10.1016\/j.jaci.2024.02.011_bib93","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1398-9995.2010.02494.x","article-title":"Physical interactions between mast cells and eosinophils: a novel mechanism enhancing eosinophil survival in\u00a0vitro","volume":"66","author":"Elishmereni","year":"2011","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2024.02.011_bib94","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.1164\/rccm.202109-2093ST","article-title":"Use of fractional exhaled nitric oxide to guide the treatment of asthma: an official American Thoracic Society clinical practice guideline","volume":"204","author":"Khatri","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2024.02.011_bib95","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1046\/j.1440-1843.2003.00495.x","article-title":"Exhaled nitric oxide continues to reflect airway hyperresponsiveness and disease activity in inhaled\u00a0corticosteroid\u2013treated adult asthmatic patients","volume":"8","author":"Reid","year":"2003","journal-title":"Respirology"},{"key":"10.1016\/j.jaci.2024.02.011_bib97","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1164\/ajrccm.157.1.9703002","article-title":"Dissociation between airway inflammation and airway hyperresponsiveness in allergic asthma","volume":"157","author":"Crimi","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2024.02.011_bib98","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1378\/chest.89.4.477","article-title":"Bronchoalveolar lavage of allergic asthmatic patients following allergen bronchoprovocation","volume":"89","author":"Metzger","year":"1986","journal-title":"Chest"},{"key":"10.1016\/j.jaci.2024.02.011_bib99","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/0091-6749(82)90038-0","article-title":"Allergen-induced increase in bronchial responsiveness to histamine: relationship to the late asthmatic response and change in airway caliber","volume":"70","author":"Cartier","year":"1982","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.02.011_bib100","first-page":"131","article-title":"Mechanisms of bronchial hyperreactivity in normal subjects after upper respiratory tract infection","volume":"113","author":"Empey","year":"1976","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.jaci.2024.02.011_bib101","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1164\/ajrccm\/143.2.358","article-title":"Bronchial hyperresponsiveness in normal subjects during attenuated influenza virus infection","volume":"143","author":"Laitinen","year":"1991","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.jaci.2024.02.011_bib102","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1164\/ajrccm\/136.6.1403","article-title":"Protective effect of antiasthma drugs on late asthmatic reactions and increased airway responsiveness induced by toluene diisocyanate in sensitized subjects","volume":"136","author":"Mapp","year":"1987","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.jaci.2024.02.011_bib103","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1164\/ajrccm\/136.1.36","article-title":"Bronchoalveolar neutrophilia during late asthmatic reactions induced by toluene diisocyanate","volume":"136","author":"Fabbri","year":"1987","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.jaci.2024.02.011_bib104","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1183\/09059180.05.00009502","article-title":"Impact of environmental factors on lung defences","volume":"14","author":"Olivieri","year":"2005","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.jaci.2024.02.011_bib105","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1152\/japplphysiol.00714.2012","article-title":"Last word on point: alterations in airway smooth muscle phenotype do cause airway hyperresponsiveness in asthma","volume":"113","author":"Gunst","year":"2012","journal-title":"J Appl Physiol (1985)"},{"key":"10.1016\/j.jaci.2024.02.011_bib106","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1172\/JCI124606","article-title":"Epithelial cell\u2013derived cytokines: more than just signaling the alarm","volume":"129","author":"Roan","year":"2019","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2024.02.011_bib107","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/j.jaci.2013.08.052","article-title":"Increased density of intraepithelial mast cells in patients with exercise-induced bronchoconstriction regulated through epithelially derived thymic stromal lymphopoietin and IL-33","volume":"133","author":"Lai","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.02.011_bib108","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1164\/ajrccm\/140.6.1745","article-title":"Bronchial biopsies in asthma. An ultrastructural, quantitative study and correlation with hyperreactivity","volume":"140","author":"Jeffery","year":"1989","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.jaci.2024.02.011_bib109","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1164\/rccm.200403-305OC","article-title":"Abnormal alveolar attachments with decreased elastic fiber content in distal lung in fatal asthma","volume":"170","author":"Mauad","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2024.02.011_bib110","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S0091-6749(97)70050-2","article-title":"Protective effect of inhaled budesonide against unlimited airway narrowing to methacholine in atopic patients with asthma","volume":"99","author":"Booms","year":"1997","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.02.011_bib111","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1136\/thorax.57.4.309","article-title":"Airway inflammation, basement membrane thickening and bronchial hyperresponsiveness in asthma","volume":"57","author":"Ward","year":"2002","journal-title":"Thorax"},{"key":"10.1016\/j.jaci.2024.02.011_bib112","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/00063198-200201000-00009","article-title":"Lung elastic recoil in acute and chronic asthma","volume":"8","author":"Gelb","year":"2002","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.jaci.2024.02.011_bib113","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.jaci.2008.02.017","article-title":"Expression of smooth muscle and extracellular matrix proteins in relation to airway function in asthma","volume":"121","author":"Slats","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.02.011_bib114","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1378\/chest.112.1.45","article-title":"Bronchial subepithelial fibrosis correlates with airway responsiveness to methacholine","volume":"112","author":"Boulet","year":"1997","journal-title":"Chest"},{"key":"10.1016\/j.jaci.2024.02.011_bib96","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/occmed\/kqv158","article-title":"Bronchial hyperresponsiveness","volume":"66","author":"Borak","year":"2016","journal-title":"Occup Med (Lond)"},{"key":"10.1016\/j.jaci.2024.02.011_bib115","doi-asserted-by":"crossref","first-page":"761","DOI":"10.3389\/fimmu.2020.00761","article-title":"More than just a barrier: the immune functions of the airway epithelium in asthma pathogenesis","volume":"11","author":"Frey","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2024.02.011_bib116","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1164\/ajrccm.158.6.9712073","article-title":"Collagen deposition in large airways may not differentiate severe asthma from milder forms of the disease","volume":"158","author":"Chu","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2024.02.011_bib117","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3390\/bioengineering8010013","article-title":"Role of collagen in airway mechanics","volume":"8","author":"Liu","year":"2021","journal-title":"Bioengineering (Basel)"},{"key":"10.1016\/j.jaci.2024.02.011_bib118","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/MCP.0b013e32831da8d3","article-title":"Mucus hypersecretion in asthma: causes and effects","volume":"15","author":"Evans","year":"2009","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.jaci.2024.02.011_bib119","first-page":"1176","article-title":"Mucoactive agents for airway mucus hypersecretory diseases","volume":"52","author":"Rogers","year":"2007","journal-title":"Respir Care"},{"key":"10.1016\/j.jaci.2024.02.011_bib120","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1136\/thx.2008.111435","article-title":"Increased myoepithelial cells of bronchial submucosal glands in fatal asthma","volume":"65","author":"Green","year":"2010","journal-title":"Thorax"},{"key":"10.1016\/j.jaci.2024.02.011_bib121","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1152\/japplphysiol.00342.2018","article-title":"Airway smooth muscle proliferation and inflammation in asthma","volume":"125","author":"James","year":"2018","journal-title":"J Appl Physiol (1985)"},{"key":"10.1016\/j.jaci.2024.02.011_bib122","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1080\/14728222.2020.1783242","article-title":"Thymic stromal lymphopoietin: its role and potential as a therapeutic target in asthma","volume":"24","author":"Gauvreau","year":"2020","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.jaci.2024.02.011_bib123","doi-asserted-by":"crossref","first-page":"14466","DOI":"10.3390\/ijms232214466","article-title":"Human lung mast cells: therapeutic implications in asthma","volume":"23","author":"Poto","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jaci.2024.02.011_bib124","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00441-016-2566-8","article-title":"Airway remodeling in asthma: what really matters","volume":"367","author":"Fehrenbach","year":"2017","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.jaci.2024.02.011_bib125","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3389\/fmed.2020.00191","article-title":"Airway remodeling in asthma","volume":"7","author":"Hough","year":"2020","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jaci.2024.02.011_bib126","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/ACI.0000000000000703","article-title":"Exploring the origin and regulatory role of mast cells in asthma","volume":"21","author":"Murphy","year":"2021","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.02.011_bib127","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jaci.2006.03.040","article-title":"Bronchial responsiveness to leukotriene D4 is resistant to inhaled fluticasone propionate","volume":"118","author":"Gyllfors","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.02.011_bib128","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1183\/09031936.00017707","article-title":"Mast cell regulation of airway smooth muscle function in asthma","volume":"29","author":"Bradding","year":"2007","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2024.02.011_bib129","doi-asserted-by":"crossref","first-page":"2000260","DOI":"10.1183\/13993003.00260-2020","article-title":"Anti-alarmins in asthma: targeting the airway epithelium with next-generation biologics","volume":"56","author":"Porsbjerg","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2024.02.011_bib130","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.clim.2012.03.001","article-title":"Dynamic role of epithelium-derived cytokines in asthma","volume":"143","author":"Bartemes","year":"2012","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaci.2024.02.011_bib131","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/j.chest.2016.10.042","article-title":"Epithelial-derived cytokines in asthma","volume":"151","author":"Mitchell","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.jaci.2024.02.011_bib132","doi-asserted-by":"crossref","first-page":"863","DOI":"10.3109\/02770903.2014.921196","article-title":"IL-33 promotes airway remodeling and is a marker of asthma disease severity","volume":"51","author":"Guo","year":"2014","journal-title":"J Asthma"},{"key":"10.1016\/j.jaci.2024.02.011_bib133","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/all.12593","article-title":"IL-33 drives airway hyper-responsiveness through IL-13\u2013mediated mast cell: airway smooth muscle crosstalk","volume":"70","author":"Kaur","year":"2015","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2024.02.011_bib134","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jaci.2008.03.026","article-title":"Adenosine induces airway hyperresponsiveness through activation of A3 receptors on mast cells","volume":"122","author":"Hua","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.02.011_bib135","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.4049\/jimmunol.181.4.2772","article-title":"Human airway smooth muscle promotes human lung mast cell survival, proliferation, and constitutive activation: cooperative roles for CADM1, stem cell factor, and IL-6","volume":"181","author":"Hollins","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2024.02.011_bib136","doi-asserted-by":"crossref","first-page":"4682","DOI":"10.4049\/jimmunol.0803832","article-title":"Human airway smooth muscle cells from asthmatic individuals have CXCL8 hypersecretion due to increased NF-kappa B p65, C\/EBP beta, and RNA polymerase II binding to the CXCL8 promoter","volume":"183","author":"John","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2024.02.011_bib137","doi-asserted-by":"crossref","first-page":"6105","DOI":"10.4049\/jimmunol.1000638","article-title":"Mast cell fibroblastoid differentiation mediated by airway smooth muscle in asthma","volume":"185","author":"Kaur","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2024.02.011_bib138","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0061579","article-title":"CADM1 is a key receptor mediating human mast cell adhesion to human lung fibroblasts and airway smooth muscle cells","volume":"8","author":"Moiseeva","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jaci.2024.02.011_bib139","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jaci.2008.05.020","article-title":"Airway hyperresponsiveness is dissociated from airway wall structural remodeling","volume":"122","author":"Siddiqui","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.02.011_bib140","doi-asserted-by":"crossref","first-page":"1901458","DOI":"10.1183\/13993003.01458-2019","article-title":"Novel airway smooth muscle-mast cell interactions and a role for the TRPV4-ATP axis in non-atopic asthma","volume":"56","author":"Bonvini","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2024.02.011_bib141","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jaci.2015.01.014","article-title":"Innate and adaptive T cells in asthmatic patients: relationship to severity and disease mechanisms","volume":"136","author":"Hinks","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.02.011_bib142","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1164\/rccm.202102-0355OC","article-title":"Association of differential mast cell activation with granulocytic inflammation in severe asthma","volume":"205","author":"Tiotiu","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2024.02.011_bib178","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ccm.2018.10.014","article-title":"Proinflammatory pathways in the pathogenesis of asthma","volume":"40","author":"Peebles","year":"2019","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.jaci.2024.02.011_bib179","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.jaci.2012.01.057","article-title":"Human\u00a0TH2 cells respond to cysteinyl leukotrienes through selective expression of cysteinyl leukotriene receptor 1","volume":"129","author":"Parmentier","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.02.011_bib180","doi-asserted-by":"crossref","first-page":"24s","DOI":"10.1183\/09031936.03.00000803","article-title":"Mechanisms of airway epithelial damage: epithelial\u2013mesenchymal interactions in the pathogenesis of asthma","volume":"44","author":"Holgate","year":"2003","journal-title":"Eur Respir J Suppl"},{"key":"10.1016\/j.jaci.2024.02.011_bib181","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1172\/JCI5504","article-title":"Critical roles for IL-4, IL-5, and eosinophils in chronic skin allograft rejection","volume":"103","author":"Le Moine","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2024.02.011_bib182","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1586\/1744666X.2014.967684","article-title":"The importance of TSLP in allergic disease and its role as a potential therapeutic target","volume":"10","author":"Cianferoni","year":"2014","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.jaci.2024.02.011_bib183","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/j.jaip.2022.01.040","article-title":"Targeting downstream type 2 cytokines or upstream epithelial alarmins for severe asthma","volume":"10","author":"Chan","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2024.02.011_bib143","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.jaci.2022.08.011","article-title":"Defining mast cell differentiation and heterogeneity through single-cell transcriptomics analysis","volume":"150","author":"Derakhshan","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.02.011_bib144","doi-asserted-by":"crossref","first-page":"eabb7221","DOI":"10.1126\/sciimmunol.abb7221","article-title":"Human airway mast cells proliferate and acquire distinct inflammation-driven phenotypes during type 2 inflammation","volume":"6","author":"Dwyer","year":"2021","journal-title":"Sci Immunol"},{"key":"10.1016\/j.jaci.2024.02.011_bib145","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/cea.14367","article-title":"Combined exposure to the alarmins TSLP, IL-33 and IL-25 enhances mast cell\u2013dependent contractions of human bronchi","volume":"53","author":"Belikova","year":"2023","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2024.02.011_bib146","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1136\/thx.54.5.403","article-title":"Effect of inhaled steroids on airway hyperresponsiveness, sputum eosinophils, and exhaled nitric oxide levels in patients with asthma","volume":"54","author":"van Rensen","year":"1999","journal-title":"Thorax"},{"key":"10.1016\/j.jaci.2024.02.011_bib147","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1378\/chest.11-1748","article-title":"A randomized primary care trial of steroid titration against mannitol in persistent asthma: STAMINA trial","volume":"141","author":"Lipworth","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.jaci.2024.02.011_bib148","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1016\/S0140-6736(02)11679-5","article-title":"Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial","volume":"360","author":"Green","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2024.02.011_bib149","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1513\/AnnalsATS.202106-697ED","article-title":"Selecting the optimal therapy for mild asthma","volume":"18","author":"Murphy","year":"2021","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.jaci.2024.02.011_bib150","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.jaci.2019.01.049","article-title":"Loss of bronchoprotection with ICS plus LABA treatment, beta-receptor dynamics, and the effect of alendronate","volume":"144","author":"Cardet","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.02.011_bib151","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1164\/rccm.201303-0437ST","article-title":"An official American Thoracic Society clinical practice guideline: exercise-induced bronchoconstriction","volume":"187","author":"Parsons","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2024.02.011_bib152","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1164\/ajrccm.165.8.200111-091bc","article-title":"Beta2-agonist tolerance and exercise-induced bronchospasm","volume":"165","author":"Hancox","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2024.02.011_bib153","doi-asserted-by":"crossref","first-page":"755","DOI":"10.2147\/JAA.S410592","article-title":"Effect of biologic therapies on airway hyperresponsiveness and allergic\u00a0response: a systematic literature review","volume":"16","author":"Spahn","year":"2023","journal-title":"J Asthma Allergy"},{"key":"10.1016\/j.jaci.2024.02.011_bib154","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1152\/physrev.00023.2019","article-title":"Are we meeting the promise of endotypes and precision medicine in asthma?","volume":"100","author":"Ray","year":"2020","journal-title":"Physiol Rev"},{"key":"10.1016\/j.jaci.2024.02.011_bib155","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1159\/000090387","article-title":"Effect of omalizumab on adenosine 5\u2032-monophosphate responsiveness in subjects with allergic asthma","volume":"139","author":"Prieto","year":"2006","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaci.2024.02.011_bib156","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.anai.2023.02.016","article-title":"Efficacy of biologic therapy on airway hyperresponsiveness in asthma","volume":"131","author":"Chan","year":"2023","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2024.02.011_bib168","unstructured":"US Food and Drug Administration (FDA). Zolair (omalizumab) prescribing information, 2021."},{"key":"10.1016\/j.jaci.2024.02.011_bib169","unstructured":"FDA. Tezspire (tezepelumab) prescribing information, 2021."},{"key":"10.1016\/j.jaci.2024.02.011_bib170","unstructured":"FDA. Nucala (mepolizumab) prescribing information, 2015."},{"key":"10.1016\/j.jaci.2024.02.011_bib171","unstructured":"FDA. Fasenra (benralizumab) prescribing information, 2017."},{"key":"10.1016\/j.jaci.2024.02.011_bib172","unstructured":"FDA. Dupixent (dupilumab) prescribing information, 2017."},{"key":"10.1016\/j.jaci.2024.02.011_bib173","unstructured":"FDA. Cinqair (reslizumab) prescribing information, 2016."},{"key":"10.1016\/j.jaci.2024.02.011_bib174","doi-asserted-by":"crossref","first-page":"9825","DOI":"10.1038\/s41598-023-36642-y","article-title":"Tozorakimab (MEDI3506): an anti-IL-33 antibody that inhibits IL-33 signalling via ST2 and RAGE\/EGFR to reduce inflammation and epithelial dysfunction","volume":"13","author":"England","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.jaci.2024.02.011_bib175","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1056\/NEJMoa2024257","article-title":"Efficacy and safety of itepekimab in patients with moderate-to-severe asthma","volume":"385","author":"Wechsler","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2024.02.011_bib176","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.jaci.2021.03.044","article-title":"Astegolimab (anti-ST2) efficacy and safety in adults with severe asthma: a randomized clinical trial","volume":"148","author":"Kelsen","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.02.011_bib177","doi-asserted-by":"crossref","first-page":"3538","DOI":"10.1111\/all.15473","article-title":"Biologics and airway remodeling in severe asthma","volume":"77","author":"Varricchi","year":"2022","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2024.02.011_bib184","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1164\/ajrccm.155.6.9196083","article-title":"Inhibitory effects of an anti-IgE antibody E25 on allergen-induced early asthmatic response","volume":"155","author":"Boulet","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2024.02.011_bib185","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1164\/ajrccm.155.6.9196082","article-title":"The effect of an\u00a0anti-IgE monoclonal antibody on the early- and late-phase responses to allergen inhalation in asthmatic subjects","volume":"155","author":"Fahy","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2024.02.011_bib186","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1164\/ajrccm.160.3.9810012","article-title":"Effect of aerosolized anti-IgE (E25) on airway responses to inhaled allergen in asthmatic subjects","volume":"160","author":"Fahy","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2024.02.011_bib157","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1159\/000070434","article-title":"Immunological and clinical changes in allergic asthmatics following treatment with omalizumab","volume":"131","author":"Noga","year":"2003","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaci.2024.02.011_bib158","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1164\/rccm.200312-1651OC","article-title":"Effects\u00a0of treatment with anti\u2013immunoglobulin E antibody omalizumab on airway\u00a0inflammation in allergic asthma","volume":"170","author":"Djukanovic","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2024.02.011_bib187","doi-asserted-by":"crossref","first-page":"S263","DOI":"10.1016\/j.jaci.2008.12.1020","article-title":"1022 Effects of omalizumab (Xolair) on airway hyperresponsiveness","volume":"123","author":"Patel","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.02.011_bib188","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1398-9995.2008.01881.x","article-title":"Eosinophils in bronchial mucosa of asthmatics after allergen challenge: effect of anti-IgE treatment","volume":"64","author":"van Rensen","year":"2009","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2024.02.011_bib189","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.anai.2014.10.012","article-title":"Omalizumab therapy for asthma patients with poor adherence to inhaled corticosteroid therapy","volume":"114","author":"Hendeles","year":"2015","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2024.02.011_bib190","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1016\/S0140-6736(00)03496-6","article-title":"Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response","volume":"356","author":"Leckie","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2024.02.011_bib159","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1164\/rccm.200208-789OC","article-title":"Eosinophil\u2019s role remains uncertain as anti\u2013interleukin-5 only partially depletes numbers in asthmatic airway","volume":"167","author":"Flood-Page","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2024.02.011_bib160","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1056\/NEJMoa0808991","article-title":"Mepolizumab and exacerbations of refractory eosinophilic asthma [supplementary materials]","volume":"360","author":"Haldar","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2024.02.011_bib164","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1056\/NEJMoa1402895","article-title":"Effects of an anti-TSLP antibody on allergen-induced asthmatic responses","volume":"370","author":"Gauvreau","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2024.02.011_bib162","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/S2213-2600(21)00226-5","article-title":"Effect of tezepelumab on airway inflammatory cells, remodelling, and hyperresponsiveness in patients with moderate-to-severe uncontrolled asthma (CASCADE): a double-blind, randomised, placebo-controlled, phase 2 trial","volume":"9","author":"Diver","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaci.2024.02.011_bib163","doi-asserted-by":"crossref","first-page":"2101296","DOI":"10.1183\/13993003.01296-2021","article-title":"The effect of tezepelumab on airway hyperresponsiveness to mannitol in asthma (UPSTREAM)","volume":"59","author":"Sverrild","year":"2022","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2024.02.011_bib191","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/cea.12220","article-title":"The effects of lebrikizumab in patients with mild asthma following whole lung allergen challenge","volume":"44","author":"Scheerens","year":"2014","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2024.02.011_bib192","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S2213-2600(18)30201-7","article-title":"Effect of tralokinumab, an interleukin-13 neutralising monoclonal antibody, on eosinophilic airway inflammation in uncontrolled moderate-to-severe asthma (MESOS): a multicentre, double-blind, randomised, placebo-controlled phase 2 trial","volume":"6","author":"Russell","year":"2018","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaci.2024.02.011_bib193","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1044","article-title":"Effects of interleukin-6 receptor blockade on allergen-induced airway responses in mild asthmatics [supplementary materials]","volume":"8","author":"Revez","year":"2019","journal-title":"Clin Transl Immunol"},{"key":"10.1016\/j.jaci.2024.02.011_bib194","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1067\/mai.2003.1689","article-title":"The effects of an anti-CD11a mAb, efalizumab, on allergen-induced airway responses and airway inflammation in subjects with atopic asthma","volume":"112","author":"Gauvreau","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.02.011_bib195","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1056\/NEJMoa050580","article-title":"Evidence of a role of tumor necrosis factor alpha in refractory asthma","volume":"354","author":"Berry","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2024.02.011_bib196","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.rmed.2005.02.031","article-title":"Effect of tumor necrosis factor antagonism on allergen-mediated asthmatic airway inflammation","volume":"99","author":"Rouhani","year":"2005","journal-title":"Respir Med"},{"key":"10.1016\/j.jaci.2024.02.011_bib197","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/S0140-6736(07)61600-6","article-title":"Effect of an interleukin-4 variant on late phase asthmatic response to allergen challenge\u00a0in\u00a0asthmatic patients: results of two phase 2a studies","volume":"370","author":"Wenzel","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2024.02.011_bib198","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1164\/rccm.201008-1210OC","article-title":"Effects of interleukin-13 blockade on allergen-induced airway responses in mild atopic asthma","volume":"183","author":"Gauvreau","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2024.02.011_bib199","first-page":"A6793","article-title":"Effect of an anti-M1 prime monoclonal antibody, MEMP1972A, in a phase II proof-of-activity allergen challenge study in patients with mild asthma","volume":"185","author":"Gauvreau","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2024.02.011_bib200","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1016\/S0140-6736(00)03497-8","article-title":"Effects of recombinant human interleukin-12 on eosinophils, airway hyper-responsiveness, and the late asthmatic response","volume":"356","author":"Bryan","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2024.02.011_bib201","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/cea.12235","article-title":"OX40L blockade and allergen-induced airway responses in subjects with mild asthma","volume":"44","author":"Gauvreau","year":"2014","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2024.02.011_bib161","doi-asserted-by":"crossref","DOI":"10.1177\/20406223221097327","article-title":"Dupilumab and tezepelumab in severe refractory asthma: new opportunities","volume":"13","author":"Ragnoli","year":"2022","journal-title":"Ther Adv Chronic Dis"},{"key":"10.1016\/j.jaci.2024.02.011_bib165","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.jaci.2009.01.059","article-title":"Thymic stromal lymphopoietin as a mediator of crosstalk between bronchial smooth muscles and mast cells","volume":"123","author":"Allakhverdi","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.02.011_bib166","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.jaci.2023.11.915","article-title":"Airway hyperresponsiveness correlates with airway TSLP in asthma independent of eosinophilic inflammation","volume":"153","author":"Andreasson","year":"2024","journal-title":"J Allergy Clin Immunol"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009167492400191X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009167492400191X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T22:59:09Z","timestamp":1731365949000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009167492400191X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":199,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S009167492400191X"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2024.02.011","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Airway hyperresponsiveness in asthma: The role of the epithelium","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2024.02.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}